“We are pleased to be partnering with List Labs in the manufacturing of our proprietary interferon alpha 2b. We believe our novel engineered interferon alpha 2b derived from our proprietary master cell bank offers important advantages that allows for a quick scale up of manufacturing, especially in terms of logistics and cost of goods, which should enable us to meet potentially large demand (subject to regulatory clearance) once our treatment is ready for distribution. List Labs with its state-of-the-art manufacturing plant and agile team is an ideal partner to help realize our vision.”
Dr. Doroudian, Altum Pharma
“We have been using your PT and FHA antigens for decades, and LOVE them!”
Harry Prince, Scientific Director for Immunology, Focus Diagnostics
“List labs staff are scientifically sound and very responsive to needs during difficult times, especially during GMP manufacturing.”
Microbiome Therapeutic Company in Phase I Clinical Trials
“Microbiome-based drugs, designated live biotherapeutic products by FDA, are quite different from other biologics because the bacterium itself is the drug. Few CDMOs in the US have the expertise to manufacture LBPs, so we were fortunate to find List Biological Laboratories in Campbell, CA to produce our LBP for Phase 2 clinical trials. List Labs successfully produced both drug substance and a complex drug product under one roof, which saved us considerable time and money. We would recommend List Labs to companies with innovative products who are looking for a manufacturer of early stage clinical products.”
Microbiome Therapeutic Company in Phase II Clinical Trials
“List Labs has consistently provided us with the highest level of service and quality for development and cGMP manufacturing of our live biotherapeutic product for Phase I clinical trials, while remaining sensitive to our cost requirements and timelines. I would strongly recommend them for any future project.”
Have a specific question about your LBP project?
Click below and let’s get started.